Navigation Links
Aureus Pharma Announces Date of 2008 Annual User Symposium
Date:7/2/2008

as well as other critical pharmaceutical topics including ADME/Drug-Drug Interactions and the hERG Channel. The information contained in the Aureus Pharma system is of primary importance to aid in lead discovery and optimization as well as to build predictive models. For further information on how Aureus Pharma helps researchers turn data into discovery visit http://www.aureus-pharma.com

Media Contact

Mary Donlan

Director of Marketing

Aureus Pharma

Phone : +33-1-40-18-57-59 / +33-6-76-19-51-77

mary.donlan@aureus-pharma.com


'/>"/>
SOURCE Aureus Pharma
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. QSB Anti-Virulence Platform Inhibits Biofilm Formation by Staphylococcus Aureus MRSA and Candida sp
2. Aureus Pharma Announces Renewal and Expansion of Licensing Agreement With Bristol-Myers Squibb for its AurSCOPE Knowledge Databases
3. New ActivePure Technology Proven To Reduce Exposure to Methicillin Resistant Staphylococcus Aureus (MRSA)
4. WuXi PharmaTech (NYSE: WX) Appoints Mr. Bob Zhu as VP of HR
5. Addrenex Pharmaceuticals Licenses New Compound to Sciele Pharma for the Treatment of Hypertension and Other Potential Indications
6. CET Life Sciences Center Welcomes Belmont University School of Pharmacy as New Tenant
7. Pharmasset Joins Russell 3000 Index
8. Peregrine Pharmaceuticals Awarded DTRA Contract Worth up to $44.4 Million to Develop Bavituximab for Viral Hemorrhagic Fevers
9. Webcast Alert: Isis Pharmaceuticals Announces a Business Update Conference Call
10. Par Pharmaceutical Receives Final Approval to Market Generic Marinol(R) CIII (Dronabinol) Capsules
11. Alseres Pharmaceuticals, Inc. Raises $5 Million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... LONDON , Sept. 18, 2014 ... near-patient testing, is performed outside a clinical laboratory. ... hence in administrating appropriate treatments and medication. POCT ... and prevalence of lifestyle diseases such as diabetes, ... and user-friendly. POCT devices are standardized to minimize ...
(Date:9/18/2014)... September 18, 2014 Texas Governor ... Sharp, Texas A&M Health Science Center CEO Brett ... of Health and Human Services (HHS), State of ... national pandemic influenza vaccine manufacturing facility in Bryan, ... anchor for the Texas A&M Biocorridor – a ...
(Date:9/18/2014)... Research and Markets has announced ... Chain Reaction, In-situ hybridization, Immunohistochemistry) Market - Trends & ... The global companion diagnostics market is expected ... to 2019. Factors such as rising need for personalized ... by the pharmaceutical industry, support from regulatory authorities, and ...
(Date:9/18/2014)... , Sept. 18, 2014 /PRNewswire/ - Oncothyreon Inc. (NASDAQ: ... previously announced concurrent but separate underwritten offerings of 10,000,000 ... the public of $2.00 per share, for expected gross ... Series A Convertible Preferred Stock at a price to ... proceeds of $20 million. Each share of Series A ...
Breaking Biology Technology:POCT Market in China 2014-2018 2Texas A&M Dedicates National Pandemic Influenza Vaccine Manufacturing Facility, on Track for 2016 Start-Up Phase 2Texas A&M Dedicates National Pandemic Influenza Vaccine Manufacturing Facility, on Track for 2016 Start-Up Phase 3Texas A&M Dedicates National Pandemic Influenza Vaccine Manufacturing Facility, on Track for 2016 Start-Up Phase 4Global Companion Diagnostics (Polymerase Chain Reaction, In-situ hybridization, Immunohistochemistry) Market - Trends & Forecasts to 2019 2Global Companion Diagnostics (Polymerase Chain Reaction, In-situ hybridization, Immunohistochemistry) Market - Trends & Forecasts to 2019 3Oncothyreon Prices $40 Million Concurrent Public Offerings of Common Stock and Preferred Stock 2Oncothyreon Prices $40 Million Concurrent Public Offerings of Common Stock and Preferred Stock 3
... Thought leaders from around the world converge on ... Biomedical, Inc., a,medical technology company that markets the ... a Scientific Advisory Board. The,Board,s purpose is to ... of Provant, new product development, and further,application of ...
... DOYLESTOWN, Pa., May 20 Recognizing National,Hepatitis B Awareness ... Foundation,and the Association of Asian Pacific Community Health Organizations,(AAPCHO) ... the Health Needs of Women and Children," on May ... Honda (CA) and Charles Dent (PA). It,will call urgent ...
... CALGARY, May 20 /PRNewswire-FirstCall/ - Oncolytics Biotech ... that it has been granted,U.S. Patent 7,374,752 ... Disorders." The claims cover pharmaceutical compositions,which comprise ... the Company with additional patent protection for,reovirus ...
Cached Biology Technology:Regenesis Biomedical Appoints Scientific Advisory Board Composed of Life Science and Electronics Experts 2Regenesis Biomedical Appoints Scientific Advisory Board Composed of Life Science and Electronics Experts 3Hepatitis B Foundation and AAPCHO Sponsor Congressional Briefing on 'Zero Tolerance for Hepatitis B' 2Oncolytics Biotech Inc. Announces Issuance of 27th U.S. Patent 2
(Date:9/18/2014)... of camouflage: you don,t just blend in, the background ... uncommon as you might think. Kathryn Feller, from the ... larval life stages of many marine species are transparent. ... most creatures cannot make transparent. Feller explains that the ... eye unit with an opaque pigment to prevent light ...
(Date:9/17/2014)... the Arts and Humanities has received a $260,000 grant ... project, "The Boundaries of the Human in the Age ... a wide-ranging series of events aimed at exploring two ... artists and researchers who are exploring the boundaries of ... humanism, and the other involves the increasingly influential hypothesis ...
(Date:9/17/2014)... and their environmental impact recently scored a major win. ... on the bags, and Governor Jerry Brown is expected ... not yielding without a fight, according to an article ... newsmagazine of the American Chemical Society. , Alexander Tullo, ... campaign logged its first small victory in 1990 when ...
Breaking Biology News(10 mins):Transparent larvae hide opaque eyes behind reflections 2Mellon Foundation awards grant for major project in the humanities and sciences 2
... (SACRAMENTO, Calif.) A new UC Davis study has found ... those who earn higher wages, adding to growing evidence that ... "Our study clarifies a link that has been assumed but ... study and professor in the UC Davis Center for Healthcare ...
... of a collaborative grant from the Samuel Waxman Cancer ... designed to kill non-Hodgkin lymphoma tumor cells. The breakthrough ... The Foundation-funded investigators include Ari Melnick, M.D., of Weill ... of Maryland and Gilbert Priv, Ph.D., of the University ...
...   , ... PRINCETON, N.J. , May 10 ... R&D services, announced today that it has created a new Discovery & ... immunology services, Biomarker Center of Excellence, and Genomics Laboratory. Leveraging its minority ...
Cached Biology News:UC Davis study links obesity with lowest earnings 2Scientists design new drug type to kill lymphoma cells 2Covance Establishes New Discovery & Translational Services Group 2Covance Establishes New Discovery & Translational Services Group 3
... mm Culture Dishes BD BioCoat Collagen I ... a uniform application of rat tail collagen type ... ,Surface : ECM/attachment factors ,Surface ... : 60 mm x 15 mm ...
The piston kit includes 2 pistons to service one F10 pump of a BioLogic DuoFlow workstation....
BD BioCoat BD MatrigelTM Matrix 100 mm Culture Dishes for hepatocytes, tissue-culture treated polystyrene with a uniform application of MATRIGEL Matrix....
The F40 piston assembly is supplied as two assemblies to service one F40 pump of a BioLogic DuoFlow workstation....
Biology Products: